| Literature DB >> 34777869 |
Sadia Rafique1, Muhammad Saleem Khan1, Rabia Unar2, Muhammad Wajid1, Ahmad Waheed1, Ali Umar1.
Abstract
BACKGROUND: This study was conducted to check anxiety level and mental stress in the 200 confirmed hepatitis C patients during the COVID-19 pandemic. The Chinese version of the Beck Anxiety Inventory (BAI) score index was used to measure the anxiety level of HCV-positive patients. BAI score index of different demographic factors such as gender, age, occupation, and education of all the sampled population was calculated.Entities:
Keywords: Anxiety; COVID-19; Hepatitis C; Mental health; Pakistan
Year: 2021 PMID: 34777869 PMCID: PMC8197598 DOI: 10.1186/s43066-021-00120-9
Source DB: PubMed Journal: Egypt Liver J ISSN: 2090-6218
Demographic characteristics of HCV-positive participants
| Participant characteristics | Respondents | |
|---|---|---|
| % | ||
| Male | 123 | 61.5 |
| Female | 77 | 38.5 |
| ≤ 25 years | 11 | 5.5 |
| 25–45 years | 109 | 54.5 |
| > 45 years | 80 | 40 |
| Student | 15 | 7.5 |
| Teachers | 36 | 18 |
| Unemployed | 15 | 7.5 |
| Agriculture | 40 | 20 |
| Own business | 20 | 10 |
| Labor workers | 41 | 20.5 |
| Public sector employee | 33 | 16.5 |
| Undergraduate | 98 | 49 |
| Graduate | 73 | 36.5 |
| Postgraduate | 29 | 14.5 |
Fig. 1BAI score of quarantined HCV patients vs non-quarantined HCV patients
Fig. 2BAI score of healthy vs HCV-positive patients
BAI score of the HCV-infected respondents classified in various subsamples
| Subsamples | BAI score | |||||
|---|---|---|---|---|---|---|
| 0–9 n (%) | 10–18 (%) | 19–29 (%) | 30–63 (%) | χ2 | P | |
| Gender | ||||||
| Male (n = 123) | 45 (36.59%) | 30 (24.39%) | 27 (21.95%) | 21 (17.07%) | 13.070 | 0.004 |
| Female (n = 77) | 13 (16.88%) | 16 (20.78%) | 22 (28.57%) | 26 (33.77%) | ||
| ≤ 25 years (n = 11) | 8 (72.73%) | 2 (18.18%) | 1 (9.09%) | 0 | 13.041 | 0.042 |
| 25–45 years (n = 109) | 29 (26.61%) | 31 (28.44%) | 18 (16.51%) | 31 (28.44%) | ||
| > 45 years (n = 80) | 31 (38.75%) | 21 (26.25%) | 14 (17.5%) | 14 (17.5%) | ||
| Students (n = 15) | 12 (80%) | 3 (20%) | 0 | 0 | 94.589 | 0.001 |
| Teachers (n = 36) | 4 (11.11%) | 12 (33.33%) | 10 (27.78%) | 10 (27.78%) | ||
| Unemployed (n = 15) | 2 (13.33%) | 3 (20.00%) | 8 (53.33%) | 2 (13.33%) | ||
| Agriculture (n = 40) | 26 (65%) | 11 (27.50%) | 0 | 3 (7.50%) | ||
| Own business (n = 20) | 2 (10%) | 0 | 8 (40%) | 10 (50%) | ||
| Labor workers (n = 41) | 12 (29.27%) | 12 (29.27%) | 14 (34.15%) | 3 (7.32%) | ||
| Public sector employee (n = 33) | 3 (9.09%) | 8 (24.24%) | 10 (30.30%) | 12 (36.36%) | ||
| Undergraduate (n = 98) | 63 (64.29%) | 24 (24.49%) | 6 (6.12%) | 5 (5.10%) | 55.165 | 0.002 |
| Graduate (n = 73) | 34 (46.58%) | 3 (4.11%) | 24 (32.88%) | 12 (16.44%) | ||
| Postgraduate (n = 29) | 5 (17.24%) | 9 (31.03%) | 5 (17.24%) | 10 (34.48%) | ||
| Yes (n = 32) | 0 | 0 | 11 (33.37%) | 21 (66.63%) | 45.183 | 0.004 |
| No (n = 168) | 67 (39.88%) | 32 (19.04%) | 40 (23.81%) | 29 (17.26%) | ||
Fig. 3Prevalence in HCV-positive quarantined vs HCV-positive non-quarantined patients
Prevalence of anxiety-related symptoms in HCV-infected respondents regarding COVID-19
| Sr # | Parameters | Yes | No | Not sure | χ2 | P |
|---|---|---|---|---|---|---|
| 1 | Restless due to social distancing? | 109 (54.5%) | 69 (34.5%) | 22 (11%) | 56.89 | 0.05 |
| 2 | Significant weight loss or gain | 69 (34.5%) | 117 (58.5%) | 14 (7%) | 79.69 | 0.003 |
| 3 | Insomnia or excessive sleep | 69 (34.5%) | 124 (62%) | 7 (3.50%) | 102.79 | 0.004 |
| 4 | Repeated thoughts of death? | 84 (42%) | 105 (52.5%) | 11 (5.5%) | 73.03 | 0.013 |
| 5 | Lacking interest in daily life? | 123 (61.5%) | 48 (24%) | 29 (14.5%) | 74.11 | 0.012 |
| 6 | Fear leaving house | 83 (41.5%) | 107 (53.5%) | 10 (5%) | 76.57 | 0.001 |
| 7 | Avoided avail healthcare facilities | 116 (58%) | 63 (31.5%) | 21 (10.5%) | 67.99 | 0.011 |
| 8 | Limited physical contact | 164 (82%) | 26 (13%) | 10 (5%) | 215.08 | 0.004 |
| 9 | Avoid watching the news | 116 (58%) | 74 (37%) | 10 (5%) | 85.48 | 0.002 |
Fig. 4Percentage proactive measures taken by HCV-infected respondents against COVID-19 infection